Medlab Clinical Ltd
ASX:MDC

Watchlist Manager
Medlab Clinical Ltd Logo
Medlab Clinical Ltd
ASX:MDC
Watchlist
Price: 6.6 AUD -4.21%
Market Cap: 15.1m AUD

Wall Street
Price Targets

MDC Price Targets Summary
Medlab Clinical Ltd

There are no price targets for MDC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Medlab Clinical Ltd Competitors:
Price Targets
ADCT
ADC Therapeutics SA
119% Upside
2157
Lepu Biopharma Co Ltd
95% Upside
GLPG
Galapagos NV
12% Upside
2616
CStone Pharmaceuticals
136% Upside
ENTA
Enanta Pharmaceuticals Inc
27% Upside
688363
Bloomage Biotechnology Corp Ltd
8% Upside
TNG
Transgene SA
62% Upside
INSM
Insmed Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Medlab Clinical Ltd

For the last 8 years the compound annual growth rate for Medlab Clinical Ltd's revenue is -48%. The projected CAGR for the next 1 year is 46 941%.

-48%
Past Growth
46 941%
Estimated Growth
Estimates Accuracy
-76%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medlab Clinical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Medlab Clinical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDC's stock price target?
Not Available

MDC doesn't have any price targets made by Wall Street professionals.

What is Medlab Clinical Ltd's Revenue forecast?
Projected CAGR
46 941%

For the last 8 years the compound annual growth rate for Medlab Clinical Ltd's revenue is -48%. The projected CAGR for the next 1 year is 46 941%.

Back to Top